Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2024-05-15 Sale | 2024-05-17 4:05 pm | GERON CORP | GERN | LAWLIS V BRYAN Director | 35,000 | $3.75 | $131,250 | 0 (Direct) | View |
2023-05-11 Sale | 2023-05-11 9:01 pm | GERON CORP | GERN | LAWLIS V BRYAN Director | 35,000 | $3 | $105,000 | 0 (Direct) | View |
2023-04-03 Sale | 2023-04-04 7:59 pm | BIOMARIN PHARMACEUTICAL INC | BMRN | LAWLIS V BRYAN Director | 8,500 | $97.09 | $825,265 | 28,950 (Direct) | View |
2022-04-14 Sale | 2022-04-18 8:22 pm | BIOMARIN PHARMACEUTICAL INC | BMRN | LAWLIS V BRYAN Director | 4,250 | $83.66 | $355,555 | 23,970 (Direct) | View |
2022-01-14 Sale | 2022-01-19 6:34 pm | BIOMARIN PHARMACEUTICAL INC | BMRN | LAWLIS V BRYAN Director | 4,250 | $87.61 | $372,343 | 28,220 (Direct) | View |
2021-04-15 Sale | 2021-04-19 4:09 pm | BIOMARIN PHARMACEUTICAL INC | BMRN | LAWLIS V BRYAN Director | 7,500 | $76.9 | $576,750 | 18,850 (Direct) | View |
2021-02-16 Sale | 2021-02-18 6:43 pm | BIOMARIN PHARMACEUTICAL INC | BMRN | LAWLIS V BRYAN Director | 7,500 | $87.41 | $655,575 | 26,350 (Direct) | View |
2020-06-05 Sale | 2020-06-09 6:04 pm | BIOMARIN PHARMACEUTICAL INC | BMRN | LAWLIS V BRYAN Director | 4,430 | $107.46 | $476,048 | 18,850 (Direct) | View |
2020-03-16 Sale | 2020-03-18 8:46 pm | BIOMARIN PHARMACEUTICAL INC | BMRN | LAWLIS V BRYAN Director | 8,360 | $76.01 | $635,470 | 18,980 (Direct) | View |
2019-12-17 Sale | 2019-12-19 8:09 pm | BIOMARIN PHARMACEUTICAL INC | BMRN | LAWLIS V BRYAN Director | 3,750 | $83.36 | $312,600 | 27,340 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2024-05-15 Exercise | 2024-05-17 4:05 pm | N/A N/A | GERON CORP | GERN | LAWLIS V BRYAN Director | 35,000 | $1.94 | 0 (Direct) | View |
2024-05-15 Exercise | 2024-05-17 4:05 pm | N/A 2024-05-20 | GERON CORP | GERN | LAWLIS V BRYAN Director | 35,000 | $0 | 0 (Direct) | View |
2024-05-09 Option Award | 2024-05-10 4:05 pm | N/A 2034-05-08 | GERON CORP | GERN | LAWLIS V BRYAN Director | 180,000 | $0 | 180,000 (Direct) | View |
2023-05-31 Option Award | 2023-06-02 7:32 pm | N/A 2033-05-30 | GERON CORP | GERN | LAWLIS V BRYAN Director | 125,000 | $0 | 125,000 (Direct) | View |
2023-05-23 Option Award | 2023-05-24 6:27 pm | N/A N/A | BIOMARIN PHARMACEUTICAL INC | BMRN | LAWLIS V BRYAN Director | 4,190 | $0 | 33,140 (Direct) | View |
2023-05-11 Exercise | 2023-05-11 9:01 pm | N/A 2023-05-22 | GERON CORP | GERN | LAWLIS V BRYAN Director | 35,000 | $0 | 0 (Direct) | View |
2023-05-11 Exercise | 2023-05-11 9:01 pm | N/A N/A | GERON CORP | GERN | LAWLIS V BRYAN Director | 35,000 | $1.1 | 0 (Direct) | View |
2023-04-03 Exercise | 2023-04-04 7:59 pm | 2013-11-15 2023-05-14 | BIOMARIN PHARMACEUTICAL INC | BMRN | LAWLIS V BRYAN Director | 8,500 | $0 | 28,950 (Direct) | View |
2023-04-03 Exercise | 2023-04-04 7:59 pm | N/A N/A | BIOMARIN PHARMACEUTICAL INC | BMRN | LAWLIS V BRYAN Director | 8,500 | $67.81 | 28,950 (Direct) | View |
2022-06-07 Option Award | 2022-06-09 9:15 pm | N/A 2032-06-06 | Aeglea BioTherapeutics Inc. | AGLE | LAWLIS V BRYAN Director | 43,000 | $0 | 43,000 (Direct) | View |
2022-05-24 Option Award | 2022-05-26 9:15 pm | N/A N/A | BIOMARIN PHARMACEUTICAL INC | BMRN | LAWLIS V BRYAN Director | 4,980 | $0 | 28,950 (Direct) | View |
2022-05-10 Option Award | 2022-05-11 6:16 pm | N/A 2032-05-09 | GERON CORP | GERN | LAWLIS V BRYAN Director | 125,000 | $0 | 125,000 (Direct) | View |
2022-04-14 Exercise | 2022-04-18 8:22 pm | N/A N/A | BIOMARIN PHARMACEUTICAL INC | BMRN | LAWLIS V BRYAN Director | 4,250 | $37.46 | 23,970 (Direct) | View |
2022-04-14 Exercise | 2022-04-18 8:22 pm | 2012-11-08 2022-05-07 | BIOMARIN PHARMACEUTICAL INC | BMRN | LAWLIS V BRYAN Director | 4,250 | $0 | 23,970 (Direct) | View |
2022-01-14 Exercise | 2022-01-19 6:34 pm | N/A N/A | BIOMARIN PHARMACEUTICAL INC | BMRN | LAWLIS V BRYAN Director | 4,250 | $37.46 | 28,220 (Direct) | View |
2022-01-14 Exercise | 2022-01-19 6:34 pm | 2012-11-08 2022-05-07 | BIOMARIN PHARMACEUTICAL INC | BMRN | LAWLIS V BRYAN Director | 4,250 | $0 | 28,220 (Direct) | View |
2021-06-08 Option Award | 2021-06-09 5:23 pm | N/A 2031-06-07 | Aeglea BioTherapeutics Inc. | AGLE | LAWLIS V BRYAN Director | 40,000 | $0 | 40,000 (Direct) | View |
2021-05-25 Option Award | 2021-05-27 7:02 pm | N/A N/A | BIOMARIN PHARMACEUTICAL INC | BMRN | LAWLIS V BRYAN Director | 5,120 | $0 | 23,970 (Direct) | View |
2021-05-11 Option Award | 2021-05-13 9:16 pm | N/A 2031-05-10 | GERON CORP | GERN | LAWLIS V BRYAN Director | 83,000 | $0 | 83,000 (Direct) | View |
2021-04-15 Exercise | 2021-04-19 4:09 pm | 2011-11-12 2021-05-11 | BIOMARIN PHARMACEUTICAL INC | BMRN | LAWLIS V BRYAN Director | 7,500 | $0 | 18,850 (Direct) | View |
2021-04-15 Exercise | 2021-04-19 4:09 pm | N/A N/A | BIOMARIN PHARMACEUTICAL INC | BMRN | LAWLIS V BRYAN Director | 7,500 | $26.49 | 18,850 (Direct) | View |
2021-02-16 Exercise | 2021-02-18 6:43 pm | 2011-11-12 2021-05-11 | BIOMARIN PHARMACEUTICAL INC | BMRN | LAWLIS V BRYAN Director | 7,500 | $0 | 26,350 (Direct) | View |
2021-02-16 Exercise | 2021-02-18 6:43 pm | N/A N/A | BIOMARIN PHARMACEUTICAL INC | BMRN | LAWLIS V BRYAN Director | 7,500 | $26.49 | 26,350 (Direct) | View |
2021-01-11 Option Award | 2021-01-13 4:25 pm | N/A 2031-01-11 | Coherus BioSciences Inc. | CHRS | LAWLIS V BRYAN Director | 20,000 | $0 | 20,000 (Direct) | View |
2020-06-08 Option Award | 2020-06-10 4:24 pm | N/A 2030-06-07 | Aeglea BioTherapeutics Inc. | AGLE | LAWLIS V BRYAN Director | 28,100 | $0 | 28,100 (Direct) | View |
2020-06-05 Option Award | 2020-06-09 6:12 pm | N/A 2030-06-04 | GERON CORP | GERN | LAWLIS V BRYAN Director | 83,000 | $0 | 83,000 (Direct) | View |
2020-05-27 Option Award | 2020-05-29 5:38 pm | N/A N/A | BIOMARIN PHARMACEUTICAL INC | BMRN | LAWLIS V BRYAN Director | 4,300 | $0 | 23,280 (Direct) | View |
2020-03-17 Exercise | 2020-03-18 8:46 pm | N/A N/A | BIOMARIN PHARMACEUTICAL INC | BMRN | LAWLIS V BRYAN Director | 3,750 | $21.51 | 18,980 (Direct) | View |
2020-03-17 Exercise | 2020-03-18 8:46 pm | 2010-11-12 2020-05-11 | BIOMARIN PHARMACEUTICAL INC | BMRN | LAWLIS V BRYAN Director | 3,750 | $0 | 18,980 (Direct) | View |
2020-01-10 Option Award | 2020-01-14 5:52 pm | N/A 2030-01-10 | Coherus BioSciences Inc. | CHRS | LAWLIS V BRYAN Director | 20,000 | $0 | 20,000 (Direct) | View |
2019-12-17 Exercise | 2019-12-19 8:09 pm | N/A N/A | BIOMARIN PHARMACEUTICAL INC | BMRN | LAWLIS V BRYAN Director | 3,750 | $21.51 | 27,340 (Direct) | View |
2019-12-17 Exercise | 2019-12-19 8:09 pm | 2010-11-12 2020-05-11 | BIOMARIN PHARMACEUTICAL INC | BMRN | LAWLIS V BRYAN Director | 3,750 | $0 | 27,340 (Direct) | View |